Manipal Health Enterprises’ ₹9,275.22 crore IPO entered its final day of subscription today, July 31, 2026, with a price band of ₹560 to ₹590 per share. As of 10:40 AM on Day 3, the IPO had been subscribed 0.47 times.
The basis of allotment is expected to be finalised on August 3, 2026, while the shares are tentatively scheduled to be listed on the NSE and BSE on August 5, 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
29 July 2026 |
|
Subscription Closing Date |
31 July 2026 |
|
Basis of Allotment Date |
3 August 2026 |
|
Refund Initiation Date |
4 August 2026 |
|
Credit of Shares |
4 August 2026 |
|
Listing on BSE and NSE |
5 August 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
The company intends to utilise the net proceeds from the fresh issue towards:
Explore other Upcoming IPOs on BSE and NSE.
[July 31, 2026, 10:40 AM]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.60x |
|
Non-Institutional Investors (NIIs) |
0.17x |
|
Retail Individual Investors (RIIs) |
0.52x |
|
Employees |
1.62x |
|
Total |
0.47x |
Manipal Health Enterprises is among India's leading multispecialty hospital chains, operating 49 hospitals with 13,037 licensed beds across 14 states and union territories as of March 31, 2026. It is the country's largest private hospital network by bed capacity and the second largest by the number of hospitals. During FY26, the company served 7.63 million patients and had a network of 11,064 doctors.
The company specializes in tertiary and quaternary care, with key focus areas including cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO-R). These specialties contributed 64.3% of its gross inpatient revenue in FY26. Manipal Health has strengthened its presence through acquisitions such as AMRI Hospitals, Medica Synergie, and the Sahyadri Group, and plans to expand its capacity by adding approximately 2,426 licensed beds by 2030.
|
Particulars |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
FY24 (in ₹ crore) |
|
Revenue from operations |
10,335.75 |
8,242.25 |
6,171.63 |
|
EBITDA |
2,795.94 |
2,247.07 |
1,776.60 |
|
Profit After Tax |
916.52 |
1,081.67 |
533.20 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here